All News


JRC turns theory to practice in its disaster response capabilities

It is known best as the Commission's in-house source of scientific advice. But the JRC’s capabilities go well beyond the theory, not just in helping with oversight of EU regulations, but also in providing much-needed practical help in responding to major humanitarian crises

Pharma industry hits out at Horizon 2020 cut

Europe’s pharma industry says the €2.2B cut to Horizon 2020 is misguided, while scientists and MEPs declare themselves happy, for the most part, that the cut is less than the €2.7B originally proposed

Patents can make or break drug discovery in Poland

There are several barriers holding back science-industry collaboration, but the most urgent one is the reluctance to protect intellectual property in advance of publishing research results, according to two of Poland’s leading patent attorneys

The SME instrument: tips & tricks for greater success

Since its 2014 launch the SME instrument has attracted applications from across Europe. But the quality is low, with only 12% passing the quality threshold. Bernd Reichert, head of unit at the Executive Agency for SMEs, offers tips for success